DK1071809T3 - Multiparameter FACS test til påvisning af ændringer i cellulære parametre - Google Patents

Multiparameter FACS test til påvisning af ændringer i cellulære parametre

Info

Publication number
DK1071809T3
DK1071809T3 DK99917563T DK99917563T DK1071809T3 DK 1071809 T3 DK1071809 T3 DK 1071809T3 DK 99917563 T DK99917563 T DK 99917563T DK 99917563 T DK99917563 T DK 99917563T DK 1071809 T3 DK1071809 T3 DK 1071809T3
Authority
DK
Denmark
Prior art keywords
detect changes
cellular parameters
cell
facs test
multiparameter
Prior art date
Application number
DK99917563T
Other languages
English (en)
Inventor
Joseph Fisher
James Lorens
Donald Payan
Alexander Rossi
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/062,330 external-priority patent/US6897031B1/en
Priority claimed from US09/157,748 external-priority patent/US6461813B2/en
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1071809T3 publication Critical patent/DK1071809T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43595—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
DK99917563T 1998-04-17 1999-04-16 Multiparameter FACS test til påvisning af ændringer i cellulære parametre DK1071809T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/062,330 US6897031B1 (en) 1998-04-17 1998-04-17 Multiparameter FACS assays to detect alterations in exocytosis
US09/157,748 US6461813B2 (en) 1998-09-21 1998-09-21 Multiparameter FACS assays to detect alterations in cell cycle regulation
PCT/US1999/008345 WO1999054494A2 (en) 1998-04-17 1999-04-16 Multiparameter facs assays to detect alterations in cellular parameters

Publications (1)

Publication Number Publication Date
DK1071809T3 true DK1071809T3 (da) 2003-12-01

Family

ID=26742137

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99917563T DK1071809T3 (da) 1998-04-17 1999-04-16 Multiparameter FACS test til påvisning af ændringer i cellulære parametre

Country Status (12)

Country Link
EP (2) EP1071809B1 (da)
JP (1) JP4511033B2 (da)
CN (1) CN100334227C (da)
AT (1) ATE248226T1 (da)
AU (1) AU3565499A (da)
CA (1) CA2325597C (da)
DE (1) DE69910756T2 (da)
DK (1) DK1071809T3 (da)
ES (1) ES2207203T3 (da)
NZ (1) NZ508120A (da)
PT (1) PT1071809E (da)
WO (1) WO1999054494A2 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030215798A1 (en) 1997-06-16 2003-11-20 Diversa Corporation High throughput fluorescence-based screening for novel enzymes
US7090976B2 (en) 1999-11-10 2006-08-15 Rigel Pharmaceuticals, Inc. Methods and compositions comprising Renilla GFP
US7151847B2 (en) 2001-02-20 2006-12-19 Cytokinetics, Inc. Image analysis of the golgi complex
US6743576B1 (en) 1999-05-14 2004-06-01 Cytokinetics, Inc. Database system for predictive cellular bioinformatics
US6651008B1 (en) 1999-05-14 2003-11-18 Cytokinetics, Inc. Database system including computer code for predictive cellular bioinformatics
DE60135652D1 (de) * 2000-06-01 2008-10-16 Pasteur Institut Chimäres GPF-Aequorin als bioluminiszenter Ca++ Marker auf Einzelzellniveau
US7218764B2 (en) 2000-12-04 2007-05-15 Cytokinetics, Inc. Ploidy classification method
US7016787B2 (en) 2001-02-20 2006-03-21 Cytokinetics, Inc. Characterizing biological stimuli by response curves
US6956961B2 (en) 2001-02-20 2005-10-18 Cytokinetics, Inc. Extracting shape information contained in cell images
WO2003067210A2 (en) 2001-07-10 2003-08-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detecting the activation state of the multiple proteins in single cells
US7393656B2 (en) 2001-07-10 2008-07-01 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for risk stratification
US7381535B2 (en) 2002-07-10 2008-06-03 The Board Of Trustees Of The Leland Stanford Junior Methods and compositions for detecting receptor-ligand interactions in single cells
EP1646926A2 (en) 2003-07-18 2006-04-19 Cytokinetics, Inc. Characterizing biological stimuli by response curves
US7235353B2 (en) 2003-07-18 2007-06-26 Cytokinetics, Inc. Predicting hepatotoxicity using cell based assays
US20050014217A1 (en) 2003-07-18 2005-01-20 Cytokinetics, Inc. Predicting hepatotoxicity using cell based assays
US7745221B2 (en) * 2003-08-28 2010-06-29 Celula, Inc. Methods and apparatus for sorting cells using an optical switch in a microfluidic channel network
JP4454998B2 (ja) * 2003-09-29 2010-04-21 株式会社ニコン 細胞観察装置および細胞観察方法
US7323318B2 (en) 2004-07-15 2008-01-29 Cytokinetics, Inc. Assay for distinguishing live and dead cells
JP4557685B2 (ja) * 2004-11-15 2010-10-06 独立行政法人理化学研究所 蛍光蛋白質
EP1943332A4 (en) 2005-10-14 2011-04-13 Medimmune Inc CELLULAR DISPLAY OF ANTIBODY LIBRARIES
FR2902440B1 (fr) * 2006-06-19 2008-08-29 Univ Paris Curie Methode de detection et de denombrement des cellules en cytodierese
US20090098594A1 (en) 2007-08-21 2009-04-16 Nodality, Inc. Methods for diagnosis prognosis and methods of treatment
EP2304436A1 (en) 2008-07-10 2011-04-06 Nodality, Inc. Methods for diagnosis, prognosis and treatment
US8309306B2 (en) 2008-11-12 2012-11-13 Nodality, Inc. Detection composition
US9459246B2 (en) 2009-09-08 2016-10-04 Nodality, Inc. Induced intercellular communication
US20110193950A1 (en) * 2010-02-09 2011-08-11 Stephen Liye Chen Application of microscopic linear array scanner for measuring rate of change of live organisms
ES2577607T3 (es) * 2010-07-28 2016-07-15 Canvax Biotech Sl Nuevos sensores ultrasensibles basados en células y usos de los mismos
US9005909B2 (en) 2011-01-06 2015-04-14 Rigel Pharmaceuticals, Inc. Whole blood assay for measuring AMPK activation
EP3274719B1 (en) 2015-03-25 2021-02-24 The Board of Trustees of the Leland Stanford Junior University Single cell analysis using secondary ion mass spectrometry
EP3443123B1 (en) 2016-04-11 2021-08-11 Board of Regents, The University of Texas System Methods and compositions for detecting single t cell receptor affinity and sequence
CN110412179A (zh) * 2018-04-26 2019-11-05 缪荣明 一种液相色谱检测颗粒酶a的方法
WO2020102556A1 (en) 2018-11-15 2020-05-22 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods of prognosis and classification for preeclampsia
JP7577340B2 (ja) * 2019-10-24 2024-11-05 国立大学法人千葉大学 細胞内脂質代謝酵素活性定量測定法、細胞内脂質代謝酵素活性定量測定用キット及び脂質代謝酵素活性制御剤のスクリーニング方法
IL294764A (en) * 2020-01-15 2022-09-01 Absci Llc Activity-specific cell enrichment
WO2022040187A1 (en) 2020-08-17 2022-02-24 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods of predicting time to onset of labor
EP4343775A1 (en) 2022-09-22 2024-03-27 SurgeCare A method for determining a medical outcome for an individual, related electronic system and computer program
CN120539027B (zh) * 2025-05-26 2025-12-02 古贝春集团有限公司 窖泥老化快速检测方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4304720A (en) * 1980-04-30 1981-12-08 Merck & Co., Inc. Fluorescein esters and ethers and the preparation thereof
US5266464A (en) * 1988-02-10 1993-11-30 Ict Pharmaceuticals, Inc. Method of screening for protein inhibitors and activators
WO1991002084A1 (en) * 1989-08-09 1991-02-21 Michael Reese Hospital And Medical Center Method for detection and treatment of multiple drug-resistant tumor cells and useful colchicine derivative probes
US5264341A (en) * 1989-08-30 1993-11-23 Eli Lilly And Company Selective cloning for high monoclonal antibody secreting hybridomas
JPH04252128A (ja) * 1990-08-03 1992-09-08 Systemix Inc 免疫化された宿主における変性された異種移植器官系
US5849600A (en) * 1993-11-10 1998-12-15 The Mclean Hospital Corporation Diagnostic assays for Alzheimer's disease
US5723288A (en) * 1994-05-06 1998-03-03 The University Of North Carolina At Chapel Hill Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans, and kits useful therefor
GB9506466D0 (en) * 1994-08-26 1995-05-17 Prolifix Ltd Cell cycle regulated repressor and dna element
GB9516138D0 (en) * 1995-08-05 1995-10-04 Medical Res Council Improvements in or relating to methods of screening substances
JPH09100289A (ja) * 1995-10-02 1997-04-15 Fujisawa Pharmaceut Co Ltd 新規化合物ｆｒ１９０８９５、ｆｒ１９０８７２及びｆｒ１９０８７３、その製造方法およびその用途
US20030215798A1 (en) * 1997-06-16 2003-11-20 Diversa Corporation High throughput fluorescence-based screening for novel enzymes
EP0931147A1 (en) * 1996-10-18 1999-07-28 Genentech, Inc. ANTI-ErbB2 ANTIBODIES
JPH11164694A (ja) * 1997-08-15 1999-06-22 Chugai Pharmaceut Co Ltd 細胞周期調節タンパク質

Also Published As

Publication number Publication date
CN100334227C (zh) 2007-08-29
AU3565499A (en) 1999-11-08
EP1363127A3 (en) 2004-03-24
CA2325597C (en) 2010-09-21
JP4511033B2 (ja) 2010-07-28
WO1999054494A2 (en) 1999-10-28
CA2325597A1 (en) 1999-10-28
DE69910756D1 (de) 2003-10-02
EP1071809A2 (en) 2001-01-31
ES2207203T3 (es) 2004-05-16
EP1363127A2 (en) 2003-11-19
ATE248226T1 (de) 2003-09-15
NZ508120A (en) 2003-10-31
WO1999054494A3 (en) 2000-02-10
DE69910756T2 (de) 2004-07-08
CN1304489A (zh) 2001-07-18
JP2002512362A (ja) 2002-04-23
EP1071809B1 (en) 2003-08-27
PT1071809E (pt) 2004-01-30

Similar Documents

Publication Publication Date Title
ATE248226T1 (de) Multiparameter facs test zum ermitteln von änderungen in den zellularen parametern
ATE205884T1 (de) Assays und vorrichtungen zum nachweis von extrahepatischer biliäreratresie
DE60031939D1 (de) Als Quelle und Responder betreibbare ATM-Prüfvorrichtung zur Ausführung von mehreren Tests
DK0988534T3 (da) Elektroniske fremgangsmåder og apparat til detektering af analytter
ATE354159T1 (de) Gerät und verfahren zum feststellen von gefühlen
DE59812896D1 (de) Vorrichtung zum optischen prüfen von oberflächen
DK0502928T3 (da) Fremgangsmåder til detektion af collagennedbrydning in vivo
ATE430923T1 (de) Vorrichtung zur klassifikation von geflügeleiern
ATE386815T1 (de) Methoden und syteme zur überwachung intrazellulärer bindereaktionen
DK0760089T3 (da) Test af emballager
ATE262178T1 (de) Identifizierung und charakterisierung von interagierenden molekülen
DE69914993D1 (de) Vorrichtung zur Feststellung von Verschleiss an Ketten
DE69937835D1 (de) Antikörper für apoptosemarker und anwendungsverfahren
DE60103428D1 (de) Identifizierung von zellen während kinetischer versuchsreihen
DK1410019T3 (da) Assay for kardiovaskulær sikkerhed
AR020191A1 (es) Aparato y metodo para medir amoniaco en procesos bioquimicos
EA200200435A1 (ru) Анализ лептина
PT918991E (pt) Metodo de ensaio
ATE434760T1 (de) Blutzellen-detektor, blutanalysegerät und blutanalyseverfahren unter verwendung des detektors
AU2001247420A1 (en) High throughput screening by measurement of intracellular calcium levels
DE60128292D1 (de) Zeitverzögerungsmessung unter Verwendung von in mehreren Frequenrbereichen modulierten optischen Signalen
ATE469238T1 (de) Verwendung von fluor-nmr zum screening mit hohem durchsatz
DE69918959D1 (de) Testen von optischen sende- und empfangsmodulen
DE69907667D1 (de) Verfahren zur frühzeitigen erkennung von reaktorverschmutzung bei der gasphasenpolymerisation
DE69724515D1 (de) Vorrichtung und Testsatz zum Test von Serum und dergleichen